GSK plc announced that the European Medicines Agency (EMA) has validated the marketing authorisation application (MAA) for its respiratory syncytial virus (RSV) older adult vaccine candidate....
Invitae, a leading medical genetics company, announced a partnership with AstraZeneca to use Invitae's Ciitizen natural history data in a retrospective and prospective study of patients diagnosed with cholangiocarcinoma, a rare bile duct cancer...
As pharmaceutics is a vital process when it comes to drug creation, in some cases, it will take at least ten years for a new drug to complete the pharmaceutics process. Also, 80 percent of new compounds are discontinued during the development proc...
French drugmaker Sanofi on forecast faster earnings growth this year on strong demand for its bestselling drug Dupixent and for its flu vaccines...
ServBlock, a blockchain and pharmaceutical compliance company, is collaborating with Microsoft’s Early Access Engineering programme to produce a novel business case for the use of NFT technology in meeting compliance standards...
Virax Biolabs Group Limited (Virax), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, announced the initiation of its Virax Immune Covid-19 Analytical Performance Study scheduled to...
Alembic Pharmaceuticals Limited has received final approval from the US Food & Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for paclitaxel injection USP, 30 mg/5 mL (6 mg/mL), 100 mg/16.7 mL (6 mg/mL), and 300 mg/50 mL...
Novacyt, an international specialist in clinical diagnostics, announced that the company’s genesig Real-Time PCR SARS-CoV-2 Winterplex 3G assay panel (Winterplex 3G) has been approved in the UK under the UK Health Security Agency's Medical Devices...
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to market Micafungin injection, 50 mg/vial and 100 mg/vial, single-dose vials (USRLD: Mycamine)...
The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's therapy for treating a type of multiple myeloma, the company said on Tuesday, giving another treatment option to patients with the incurable blood cancer....
, CDSCO.jpg)
